GL Biochem (Shanghai) Ltd
Firmenname:
GL Biochem (Shanghai) Ltd
Telefon:
21-61263452
E-Mail:
ymbetter@glbiochem.com
Nationalität:
China
URL:
www.glschina.com/
Produkte insgesamt:
9981
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
Produktkatalog
[Ala26, Leu27]-Melan-A (26-35);ALAGIGILTV
C43H78N10O12
[Ala26]-Melan-A/MART-1 (26-35);AAAGIGILTV
C40H72N10O12
[Ala6,D-Trp8]-Galanin (1-15)-ol;GWTLNAAwYLLGPHA-ol
C81H114N20O18
[Cys3,6, Tyr8, Pro9]-Substance P;RPCPQCFYPLM-NH2(Disulfidebridge:3-6)
141459-28-1
C61H90N16O13S3
[D-Arg25]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALrHYINLITRQRY-NH2
[Deamino-Cys1, D-Arg8]-Vasopressin, free acid;3-Mercaptopropionyl-YFQNCPrG(Disulfidebridge:1-6)
[Des-Ac]-α-MSH, amide;SYSMEHFRWGKPV-NH2
[Des-Arg10]-HOE I40;rRP-Hyp-G-Thi-S-(D-Tic)-Oic
C53H77N15O12S
[D-His26]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALRhYINLITRQRY-NH2
[D-Trp34]-Neuropeptide Y, human;YPSKPDNPGEDAPAEDMARYYSALRHYINLITRwRY-NH2
[D-Trp6,8,9]-Galanin (1-15)-ol;GWTLNwAwwLLGPHA-ol
C91H120N22O17
[D-Tyr11]-Neurotensin;Pyr-LYENKPRRPyIL
39379-15-2
C78H121N21O20
[D-Tyr6, ?-Ala11, ?-Phe13, Nle14]-Bombesin (1-14);Pyr-QRLGyQWAV-(?-A)-H-(?-F)-Nle-NH2
[D-Tyr6, ?-Ala11, Phe13, Nle14]-Bombesin (6-14);yQWAV-(?-A)-HF-Nle-NH2
[Gln11]-beta-Amyloid (1-40);DAEFRHDSGYQVHHQKLVFFAEDVGSNKGAIIGLMVGGVV
106686-61-7
C145H210N42O45
[Gln144]-PLP (139-151), Q144-PLP(139-151);HSLGKQLGHPDKF
C66H102N20O18
[Gln22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV
[Gln22]-beta-Amyloid (6-40);HDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV
[Gly22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV
[Gly30, Cys31] β-Amyloid (13-31)??NEW;HHQKLVFFAEDVGSNKGGC
[Ile34] Beta-Amyloid (25-34);GSNKGAIIGI
[Leu144]-PLP (139-151), L144-PLP(139-151);HSLGKLLGHPDKF
C67H105N19O17
[Leu27]-Melan-A, MART 1 (26-35);ELAGIGILTV
C45H80N10O14
[Leu28]-Melan-A (27-35);ALGIGILTV
C40H73N9O11
[Lys0]-γ-1-MSH (41-58), amide;KYVMGHFRWDRFG-NH2
C80H112N24O16S
[Lys4]-Sarafotoxin 6c;CTCKDMTDEECLNFCHQDVIW(Disulfidebridge:1-15and3-11)
C105H157N27O36S5
[Lys5, NMeLeu9, NIe10]-Neurokinin A (4-10);DKFVG-(NMeL)-NIe-NH2
C39H64N8O10
[Nle35] beta-Amyloid (17-42);LVFFAEDVGSNKGAIIGL-Nle-VGGVVIA
C120H196N28O33
[Nle35]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVV
[Nle35]-beta-Amyloid (1-42);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVVIA
[Nle35]-Beta-Amyloid (25-35);GSNKGAIIGL-Nle
163265-32-5
C46H83N13O14
[pS119] CREB327 (113-126), Biotinyl??;Biotin-ILSRRP(pS)YRKILND
[pSer5]-Kemptide, 5-TMR labeled;5-TMR-LRRA-pS-LG
C57H82N15O16P
[pSer5]-Kemptide, Biotinylated, Amide;Biotin-LRRA-pS-LG-NH2
C42H77N16O13PS
520 MMP FRET Substrate X;QXL?520-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-Lys(5-FAM)-NH2
520 MMP FRET Substrate VIII;QXL?520-RPKPLA-Nva-WK(5-FAM)-NH2
520 MMP FRET Substrate VII;QXL?520-PYAYWMRK(5-FAM)-NH2
520 MMP FRET Substrate VI;QXL?520-Pro-Leu-Gly-Met-Trp-Ser-Arg-Lys(5-FAM)-NH2
520 MMP FRET Substrate V;5-FAM-Pro-Leu-Gly-Leu-Dap(QXL?520)-Ala-Arg-NH2
520 MMP FRET Substrate IX;QXL?520-RPLALWRK(5-FAM)-NH2
520 MMP FRET Substrate IV;5-FAM-Pro-Leu-Ala-Nva-Dap(QXL?520)-Ala-Arg-NH2
520 MMP FRET Substrate III;QXL?520-Pro-Leu-Gly-Cys(Me)-His-Ala-Arg-Lys(5-FAM)-NH2
520 MMP FRET Substrate II;QXL?520-Pro-Leu-Ala-Leu-Trp-Ala-Arg-Lys(5-FAM)-NH2
C67H86N14O14
[pSer5]-Kemptide, Biotinylated-LC;Biotin-LC-LRRA-pS-LG
C48H85N16O15PS
[pSer5]-Kemptide, HiLyte Fluor? 488 labeled;HiLyteFluor?488-LRRA-pS-LG
[Pyr11]-beta-Amyloid (11-40);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVV
192377-94-9
C143H226N38O39S
[Pyr11]-beta-Amyloid (11-42);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
C152H242N40O41S
[Pyr3]-beta-Amyloid (3-40);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV
C187H283N51O53S
[Pyr3]-beta-Amyloid (3-42);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
183449-57-2
C196H299N53O55S1
[Ser102]-MCC (88-103), MCC (T102S);ANERADLIAYLKQASK
C78H131N23O25
[Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, human, rat;YSEEPPISLDLTFHLLREVLEEMARAEQLAQQAHSNRKLMEII-NH2
100513-58-4
C217H353N61O65S2
[Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, ovine;YSQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2
[Tyr0]-α-Calcitonin Gene Related Peptide, [Tyr0]-α-CGRP, rat;YSCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2(Disulfidebridge:2-7)
[Tyr11] Head Activator;Pyr-PPGGSKVILY
C54H84N12O15
[Tyr22]-α-CGRP (22-37), rat;YVKDNFVPTNVGSEAF-NH2
[Tyr8]-Atrial Natriuretic Peptide (5-27), [Tyr8]-Atriopeptin II, rat;SSCYGGRIDRIGAQSGLGCNSFR(Disulfidebridge:3-19)
C98H156N34O33S2
Beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV
2837b, Hemoglobin Fragment, Plasmepsin II (PM II) substrate, EDANS/ DABCYL??;EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap(DABCYL)-OH
390 MMP FRET Substrate II;Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-OH
C43H65N11O12
490 MMP FRET Substrate III;DABCYL-RPLALWRS-EDANS
C73H100N20O13S
490 MMP FRET Substrate IV;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Asp(EDANS)-Ala-Arg-NH2
C66H96N18O13S
490 MMP FRET Substrate V;NBD-RPKPLA-Nva-WK(DMC)-NH2
C76H109N21O15
490 MMP FRET Substrate VI;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Dap(AMCA)-Ala-Arg-NH2
C64H92N18O12
490 MMP FRET Substrate VII;Dabcyl-Lys-Pro-Leu-Ala-Nva-Dap(AMCA-X)-NH2
C62H88N14O11
4A/4B Peptide (2);DEMEECASHLPY-K(Ac)-NH2
C67H101N17O24S2
4A/4B Peptide (3), EDANS-labeled;DEMEECASHLPY-E(EDANS)-NH2
C76H106N18O27S3
520 MMP FRET Substrate I;QXL520?-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-Lys(5-FAM)-NH2
5A, pNA-labeled;EDVV-Abu-C-pNA
C32H48N8O12S
580 MMP FRET Substrate I;QXL?570-Lys-Pro-Leu-Ala-Nva-Dap(5-TAMRA)-Ala-Arg-NH2
520 MMP FRET Substrate XVII;QXL?520-Lys-Pro-Leu-Ala-Nva-Dap(5-FAM)-Ala-Arg-NH2
520 MMP FRET Substrate XVI;QXL?520-RPKPQQFWK(5-FAM)-NH2
520 MMP FRET Substrate XV;QXL?520-γ-Abu-Pro-Gln-Gly-Leu-Dab(5-FAM)-Ala-Lys-NH2
520 MMP FRET Substrate XIV;QXL?520-γ-Abu-Pro-Cha-Abu-Smc-His-Ala-Dab(5-FAM)-Ala-Lys-NH2(Smc=S-Methyl-L-cysteine)
520 MMP FRET Substrate XIII;5-FAM-RPKPVE-Nva-WRK(QXL?520)-NH2
520 MMP FRET Substrate XII;5-FAM-RPKPYA-Nva-WM-K(QXL?520)-NH2
520 MMP FRET Substrate XI;5-FAM-Pro-Cha-Gly-Nva-His-Ala-Dap(QXL?520)-NH2
β-Secretase Substrate I, Fluorogenic
δ1-MSH, amide
72629-65-3
C72H97N21O14S
γ-2-MSH (41-58), amide;YVMGHFRWDRFG-NH2
799841-81-9
C74H100N22O15S
γ3-MSH:GAMMA3-MSH
72629-64-2
C126H188N44O37S
γ-Endorphin
60893-02-9
C83H131N19O27S
γ-MSH (3-8)
98640-70-1
C39H52N12O7S
γ-TAC4 (30-61)-NH2??;TEAETWEGAGPSIQLQLQEVKTGKASQFFGLM-NH2
δ-Endorphin (bovine, camel, mouse, ovine)
66954-40-3
C136H215N35O39S
δ-Endorphin (human)
76622-84-9
C139H217N33O40S
BREMELANOTIDE
189691-06-3
C50H68N14O10
Cetrorelix Acid;
120287-85-6
C70H92ClN17O14
Ganirelix Acetate
123246-29-7
C80H113ClN18O13
(Arg)9, FAM-labeled;FAM-RRRRRRRRR
C75H120N36O16
(Arg)9, TAMRA-labeled;TAMRA-RRRRRRRRR
C83H134ClN39O16
(pS8, pS13) Eucariotic Translation Initiation Factor 2B, eIF2B??;RRAAEELDpSRAGpSPQL
(Z-AR)2Rh110?2HCl;(Z-AR)2Rh110?HCl
C54H63Cl3N12O11
(Z-Arg)2Rh110 ? 2HCl;(Z-R)2Rh110?2HCl
C48H53Cl3N10O9
?-Neuroprotectin;aDLIAYL-NH2
C37H60N8O10
[4-Chloro-Phe]7,8-Substance P;RPKPQQ-F(4-Cl-F)-GLM-NH2
73646-81-8
C63H96Cl2N18O13S
[Ala144]-PLP (139-151) A144-PLP(139-151);HSLGKALGHPDKF
C64H99N19O17
[3,4-Dehydro-Pro]3-Thyrotropin Releasing Hormone, [ΔPro3]-TRH
β-Endorphin, equine
?-Bag Cell Peptide;RLRFH
C33H53N13O6
(Z-Phe-Arg)2Rh110;(Z-FR)2Rh110
C66H69ClN12O11
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
Copyright 2019 © ChemicalBook. All rights reserved